The US Food and Drug Administration (FDA) has cleared Toshiba America Medical Systems' new 16-detector row Aquilion RXL Edition CT system.
The Aquilion RXL system includes Toshiba’s Adaptive Iterative Dose Reduction 3D (AIDR 3D) technology, which is designed to work in both the raw data and image data spaces and reduces noise while attempting to maintain image quality.
The system also features Toshiba’s NEMA XR 25 Dose Check software which improves user awareness of the radiation dose administered to patients.
In addition, Aquilion RXL incorporates Toshiba’s suite of SURETechnologies, increasing clinical capabilities and significantly improving productivity.
Toshiba CT business unit senior director Satrajit Misra said Aquilion RXL is designed for the healthcare facilities who are looking for a safe, efficient and accurate CT system, combining performance and value for every-day imaging needs.
"The integrated AIDR 3D radiation dose reduction technology creates safer exams for improved patient care," Misra added.